Cargando…

Influence of chronic lymphocytic thyroiditis on the risk of persistent and recurrent disease in patients with papillary thyroid carcinoma and elevated antithyroglobulin antibodies after initial therapy()

INTRODUCTION: In patients with papillary thyroid carcinoma who have negative serum thyroglobulin after initial therapy, the risk of structural disease is higher among those with elevated antithyroglobulin antibodies compared to patients without antithyroglobulin antibodies. Other studies suggest tha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Côrtes, Marina Carvalho S., Rosario, Pedro Weslley, Mourão, Gabriela Franco, Calsolari, Maria Regina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449248/ https://www.ncbi.nlm.nih.gov/pubmed/28625809 http://dx.doi.org/10.1016/j.bjorl.2017.05.005

Ejemplares similares

Recombinant human TSH versus thyroid hormone withdrawal in adjuvant therapy with radioactive iodine of patients with papillary thyroid carcinoma and clinically apparent lymph node metastases not limited to the central compartment (cN1b)
por: Rosario, Pedro Weslley, et al.
Publicado: (2017)

Is Stimulated Thyroglobulin Necessary after Ablation in All Patients with Papillary Thyroid Carcinoma and Basal Thyroglobulin Detectable by a Second-Generation Assay?
por: Rosario, Pedro Weslley, et al.
Publicado: (2015)

Is (131)I ablation necessary for patients with low-risk papillary thyroid carcinoma and slightly elevated stimulated thyroglobulin after thyroidectomy?
por: Rosario, Pedro Weslley, et al.
Publicado: (2016)

Lung Recurrence of Papillary Thyroid Cancer Diagnosed With Antithyroglobulin Antibodies After 10 Years From Initial Treatment
por: Viola, David, et al.
Publicado: (2018)

Thyroid nodules ≤ 1 cm and papillary thyroid microcarcinomas: Brazilian experts opinion
por: Rosario, Pedro Weslley, et al.
Publicado: (2019)

Change in Antithyroglobulin Antibody Levels is a Good Predictor of Responses to Therapy in Antithyroglobulin Antibody-Positive Pediatric Papillary Thyroid Carcinoma Patients
por: Xi, Chuang, et al.
Publicado: (2022)

Thyroid nodules with highly suspicious ultrasonographic features, but with benign cytology on two occasions: is malignancy still possible?
por: Rosário, Pedro Weslley, et al.
Publicado: (2016)

Serum TSH level stability after 5 years in euthyroid adults at low risk for thyroid dysfunction
por: Rosario, Pedro Weslley, et al.
Publicado: (2018)

Noninvasive encapsulated papillary RAS-like thyroid tumor (NEPRAS) or encapsulated papillary thyroid carcinoma (PTC)
por: Rosario, Pedro Weslley
Publicado: (2020)

Association of antithyroglobulin antibodies with the development of thyroid dysfunction induced by nivolumab
por: Kimbara, Shiro, et al.
Publicado: (2018)

Radioiodine-induced oxidative stress in patients with differentiated thyroid carcinoma and effect of supplementation with vitamins C and E and selenium (antioxidants)
por: Rosário, Pedro Weslley, et al.
Publicado: (2016)

Long-term follow-up of patients with elevated IGF-1 and nadir GH > 0.4 µg/L but < 1 µg/L
por: Rosario, Pedro Weslley, et al.
Publicado: (2017)

Association of antithyroglobulin antibody with iodine nutrition and thyroid dysfunction in Nepalese children
por: Tamang, Binaya, et al.
Publicado: (2019)

Antineutrophil cytoplasmic antibodies in patients treated with methimazole: a prospective Brazilian study()
por: Andrade, Gabriela Costa, et al.
Publicado: (2018)

Antithyroglobulin Antibody as a Marker of Successful Ablation Therapy in Differentiated Thyroid Cancer
por: Dewi, Ayu Rosemeilia, et al.
Publicado: (2017)

TSH reference values in the first trimester of gestation and correlation between maternal TSH and obstetric and neonatal outcomes: a prospective Brazilian study
por: Rosario, Pedro Weslley, et al.
Publicado: (2015)

Serum PTH reference values in an adult Brazilian population: implications for the diagnosis of hyperparathyroidism
por: Rosario, Pedro Weslley, et al.
Publicado: (2019)

Pathologic Spectrum of Lymphocytic Infiltration and Recurrence of Papillary Thyroid Carcinoma
por: Kim, Hyun Gi, et al.
Publicado: (2014)

Clinical outcome of patients with differentiated thyroid cancer and raised antithyroglobulin antibody levels: a retrospective study
por: Ora, Manish, et al.
Publicado: (2021)

Antithyroglobulin Antibody Variation During Follow-Up Has a Good Prognostic Value for Preoperative Antithyroglobulin Antibody-Positive Differentiated Thyroid Cancer Patients: A Retrospective Study in Southwest China
por: Liu, Qianhui, et al.
Publicado: (2021)

TERT Promoter Mutations and Tumor Persistence/Recurrence in Papillary Thyroid Cancer
por: Myung, Jae Kyung, et al.
Publicado: (2016)

Corrigendum: Antithyroglobulin Antibody Variation During Follow-Up Has a Good Prognostic Value for Preoperative Antithyroglobulin Antibody-Positive Differentiated Thyroid Cancer Patients: A Retrospective Study in Southwest China
por: Liu, Qianhui, et al.
Publicado: (2022)

Molecular Predictors for Advanced Papillary Thyroid Carcinoma Recurrence
por: de Castro, Taciana Padilha, et al.
Publicado: (2019)

Hurthle Cells Adenoma With Distant Metastases Refractory to Radioiodine
por: Rosario, Pedro Weslley, et al.
Publicado: (2021)

Prognostic Value of Basal Serum Thyroglobulin Levels, but Not Basal Antithyroglobulin Antibody (TgAb) Levels, in Patients with Differentiated Thyroid Cancer
por: Neshandar Asli, Isa, et al.
Publicado: (2014)

Maternal hypothyroxinemia in the first trimester of gestation and association with obstetric and neonatal outcomes and iron deficiency: a prospective Brazilian study
por: Rosario, Pedro Weslley, et al.
Publicado: (2018)

Selective screening for thyroid dysfunction in pregnant women: How often do low-risk women cease to be treated following the new guidelines of the American Thyroid Association?
por: Rosario, Pedro Weslley
Publicado: (2018)

Increased Prevalence of Chronic Lymphocytic Thyroiditis in Korean Patients with Papillary Thyroid Cancer
por: Oh, Chang-Mo, et al.
Publicado: (2014)

Focal Lymphocytic Thyroiditis Nodules Share the Features of Papillary Thyroid Cancer on Ultrasound
por: Hwang, Sena, et al.
Publicado: (2015)

Clinical implications of the BRAF mutation in papillary thyroid carcinoma and chronic lymphocytic thyroiditis
por: Kim, Woon Won, et al.
Publicado: (2018)

Prognostic parameters for recurrence of papillary thyroid microcarcinoma
por: Kim, Tae Yong, et al.
Publicado: (2008)

Clinicopathological features of recurrent papillary thyroid cancer
por: Zhu, Jian, et al.
Publicado: (2015)

Impact of Multifocality on the Recurrence of Papillary Thyroid Carcinoma
por: Woo, Joohyun, et al.
Publicado: (2021)

Nutrition education in type 2 diabetic patients: comparison of individual and collective care
por: Wardi, Marina Moreno, et al.
Publicado: (2015)

In properly selected patients with differentiated thyroid cancer, antithyroglobulin antibodies decline after thyroidectomy and their sole presence should not be an indication for radioiodine ablation
por: Zavala, Luis Felipe, et al.
Publicado: (2019)

Coexistence of Chronic Lymphocytic Thyroiditis with Papillary Thyroid Carcinoma: Clinical Manifestation and Prognostic Outcome
por: Jeong, Jun Soo, et al.
Publicado: (2012)

Relationship Between Thyroid Autoantibodies and Recurrence of Papillary Thyroid Carcinoma in Children and Adolescents
por: Huang, Dongmei, et al.
Publicado: (2022)

The outcomes and prognostic factors of patients who underwent reoperation for persistent/recurrent papillary thyroid carcinoma
por: Sun, Wenyu, et al.
Publicado: (2022)

Second Adjuvant Radioiodine Therapy after Reoperation for Locoregionally Persistent or Recurrent Papillary Thyroid Carcinoma
por: Cadena-Piñeros, Enrique, et al.
Publicado: (2022)

Elevated levels of soluble PD-L1 are associated with reduced recurrence in papillary thyroid cancer
por: Aghajani, Marra Jai, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1hd71405u3ukkb5spd1atd2dn2